298 related articles for article (PubMed ID: 24161040)
1. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
2. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies.
Jennette JC; Xiao H; Falk R; Gasim AMH
Contrib Nephrol; 2011; 169():211-220. PubMed ID: 21252521
[TBL] [Abstract][Full Text] [Related]
3. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
4. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
5. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
[TBL] [Abstract][Full Text] [Related]
6. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
7. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
8. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.
Brilland B; Garnier AS; Chevailler A; Jeannin P; Subra JF; Augusto JF
Autoimmun Rev; 2020 Jan; 19(1):102424. PubMed ID: 31734405
[TBL] [Abstract][Full Text] [Related]
9. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
10. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
13. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
14. Overview of the Pathogenesis of ANCA-Associated Vasculitis.
Xiao H; Hu P; Falk RJ; Jennette JC
Kidney Dis (Basel); 2016 Mar; 1(4):205-15. PubMed ID: 27536680
[TBL] [Abstract][Full Text] [Related]
15. The functional activities of complement factor H are impaired in patients with ANCA-positive vasculitis.
Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
Clin Immunol; 2017 Feb; 175():41-50. PubMed ID: 27939215
[TBL] [Abstract][Full Text] [Related]
16. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.
Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
